FDA Approved: CELLCEPT — Supplemental Application (Genentech, Inc.)

View source ↗

Summary

FDA approved Genentech's supplemental application for Cellcept (mycophenolate mofetil), updating the labeling for prevention of organ rejection in transplant re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection
• Kidney Transplant Rejection
• Liver Transplant Rejection

Drugs mentioned

• CELLCEPT (mycophenolate mofetil hydrochloride)

Snippet

SUPPL AP for CELLCEPT (MYCOPHENOLATE MOFETIL)